Barely Significant
← all phrases

“a strong trend”

5,726 sentences · 5,726 papers · 7,352 search hits before verification · confirmed specimen

Sighted at

p=0.077

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

a strong trendp = 0.051.0× alphagold
In the subgroup of lung cancer patients, we observed the following differences that were significant or showed a strong trend when compared to baseline: sFLT (at RTduring, p = 0.05), PlGF (at RTduring and RTend, p = 0.01), VEGF-C (at RTduring and RTend, p < 0.001; at FU1, p = 0.04), VEGF-D (FU1, p < 0.001), INF-γ (FU1, p = 0.008), IL-8 (at RTend, p = 0.02; at FU1, p = 0.03; and at FU2, p = 0.03) and HGF (at FU1, p = 0.01).
a strong trendP = .051.0× alphagold
6 A meta-analysis of 18 studies involving 146,372 octogenarians reported a strong trend toward reduced mortality in OPCAB patients (odds ratio, 0.75; 95% CI, 0.56-1.00; P = .05), although statistical significance was not reached. 4 The ability of OPCAB to dampen systemic inflammatory responses, to minimize organ dysfunction, and to reduce physiologic stress may account for its lower 30-day mortality rate. 7 Although OPCAB patients received fewer grafts overall, their ICOR was significantly higher compared with ONCAB patients.
a strong trendP < 0.051.0× alphagold
Specifically, between‐group differences for PEF%p, PEF, FVC, FEV1%p, and FEV1 for the change from baseline to week 52 were statistically significant and between‐group differences for FVC%p reached a strong trend ( P < 0.05 at weeks 13, 26, and 39; P = 0.082 at week 52). 17 Overall, the results of the study indicate a consistent slowing of the decline of these pulmonary function outcomes.
a strong trendp = 0.0501.0× alphagold
5b ), a strong trend for a significant difference in EAE clinical score could be detected 11 (xCT +/+ vs. xCT −/− BM mice: 0.75 ± 0.23 vs. 0.21 ± 0.12; p = 0.050; n = 13–14) and 14 days (xCT +/+ vs. xCT −/− BM mice: 3.31 ± 0.26 vs. 2.46 ± 0.21; p = 0.054; n = 13–14) after immunization, with a better outcome for mice lacking xCT in their immune cells (Fig. 5a ).